Strategic Advisory
Our differentiated strategic advisory business has advised many of the world’s most consequential companies on how to realize their strategic vision. PJT Camberview, our shareholder advisory practice, brings decades of investor experience to deliver advice like no other.
By the Numbers
-
$1 Trillion+ M&A Deals Announced
-
55+ Fortune 100 Clients
-
40% Repeat Clients
-
125 Cross-Border M&A Transactions Across 61 Countries
-
$21 Trillion+ in Aggregate Market Cap of Shareholder Advisory Clients
-
425 Complex Proxy Votes and Campaigns
-
145+ Activism Preparedness and Defense Mandates
-
95% Success Rate in Activism Advisory
What We Do
Capabilities
Mergers & Acquisitions
Partner with public and private companies to deliver innovative, high-touch and best-in-class solutions
Capital Markets Advisory
Provide capital raising and independent advice in both the public and private markets across the entire capital structure
Complex Investor Matters
Design bespoke strategies to deliver enhanced investor relationships, shareholder support and public market valuations
Board Advisory
Provide effective solutions to boards and special committees for critical strategic, governance and shareholder matters
Activism Defense
Develop strategies to proactively mitigate and to successfully navigate shareholder activism, unsolicited approaches and other contested situations
ESG Transition
Advise traditional and emerging businesses on creative strategic solutions for the new economy
Geopolitical and Policy Advisory
Help boards and management teams navigate changing geoeconomic relationships against the backdrop of an evolving political landscape
Every Client is Important - Large and Small
-
$8.3 billion pending acquisition of Spirit Aerosystems
-
$2.3 billion pending acquisition of Infinera Corporation
-
$4.4 billion pending sale of Wireless Operations and Select Spectrum Assets to T-Mobile
-
$5 billion pending sale to SES
-
$56 billion formation of three public companies: GE Aerospace, GE Vernova and GE HealthCare
-
Multiple debt and equity transactions totaling $31.7 billion
-
$35 billion pending sale to Capital One
-
$1.9 billion pending acquisition of Hawaiian Holdings
-
Pending acquisition of DAOU Vineyards for total consideration of up to $1 billion
-
$34.3 billion merger with WestRock
-
Pivotal 2023 investor day and successful activism defense against multiple activist funds
-
Business portfolio transformation and successful activism defense against Corvex Management
-
$28.3 billion acquisition of Horizon Therapeutics
-
Sale of its two thermal power assets in the Netherlands to EP Holding
-
$720 million sale of TaxAct to Cinven
-
IPO and €10.1 billion stake purchase in Porsche
-
$4.8 billion sale of 25% in Repsol Upstream to EIG
-
$750 million lead investment in Intersect Power
-
$7.3 billion acquisition of Inmarsat
-
Successful activist defense against Carl Icahn
-
Successful activist defense against Macellum Capital Management
-
€1.9 billion acquisition of Zentiva
-
$3.6 billion acquisition of Bungie
-
$9.3 billion business combination with Cohn Robbins
-
$12.3 billion acquisition of Vifor Pharma
-
$4.0 billion sale of TCOLV’s real property assets to a partnership among Stonepeak, Cherng Family and Blackstone
-
$1.6 billion sale of TCOLV’s casino and hotel operations to MGM Resorts
-
$2.7 billion sale to Hyatt
-
$9.0 billion business combination with bowX
-
$35 billion merger with AerCap
-
$900 million acquisition of select upstream and midstream Williston Basin assets from Equinor
-
$8.0 billion sale to TRATON
-
£3.4 billion recommended offer from Caesars
-
$400 million business combination with AerSale
-
Acquisition of the XFL and partnership with RedBird Capital
-
$7 billion sale to Franklin Templeton
-
$26 billion acquisition by Charles Schwab
-
$4.25 billion sale of Bellagio Real Estate to Blackstone
-
£14.3 billion all share combination with the Stars Group
-
€210 million merger of Galletas Siro and Cerealto and carve out of the Bread & Bakery businesses
-
$17 billion combination with El Dorado Resorts
-
$63 billion acquisition of Allergan
-
$21.4 billion sale of BioPharma business to Danaher
-
$445 million acquisition of VaaS
-
$5.1 billion acquisition of Tesaro
-
$59 billion merger with Sprint
-
$48 billion cash offer from Comcast
-
$10.5 billion merger with Vistra Energy
-
$16 billion spin of hotel group into a publicly traded company
-
$3.8 billion acquisition of DreamWorks
-
$10 billion separation into two independent publicly traded companies
Strategic Advisory Partners
Up Next in What We Do